Here’s our fortnightly wrap of all the news driving ASX health stocks.

It’s been a great month for the ASX healthcare sector with 90 stocks gaining ground and just 32 losing it. Another five companies treaded water.

Code Company Price MktCap Month return Week return %Yr
CPH Creso Pharma Ltd 0.415 $ 161,778,328.00 1496 730 196
SCU Stemcell United Ltd 0.041 $ 15,446,992.37 141 156 193
AVE Avecho Biotech Ltd 0.026 $ 27,156,776.14 86 117 550
NTI Neurotech Intl 0.061 $ 27,536,384.81 165 110 281
AMT Allegra Orthopaedics 0.37 $ 38,127,609.10 147 100 68
AC8 Auscann Grp Hlgs Ltd 0.245 $ 76,091,365.68 75 81 29
MXC Mgc Pharmaceuticals 0.0375 $ 46,199,027.48 70 79 14
CP1 Cannpal Animal 0.205 $ 18,625,000.00 95 52 58
TD1 Tali Digital Limited 0.054 $ 40,462,481.77 86 50 2
JHL Jayex Healthcare Ltd 0.053 $ 9,866,788.18 47 43 83
CAN Cann Group Ltd 0.725 $ 183,590,057.04 127 42 58
EXL Elixinol Global 0.27 $ 63,877,277.19 86 42 -64
MMJ MMJ Group Hlds Ltd 0.175 $ 37,942,407.53 67 40 13
RHY Rhythm Biosciences 0.845 $ 161,196,648.80 238 39 566
RHT Resonance Health 0.215 $ 68,955,459.62 34 34 -2
ZLD Zelira Therapeutics 0.11 $ 112,605,681.77 49 33 71
VBS Vectus Biosystems 1.35 $ 40,835,458.26 40 27 129
PIQ Proteomics Int Lab 0.69 $ 67,664,289.38 35 27 126
APH AP Hemp Ltd 0.415 $ 21,031,926.00 113 22 144
THC THC Global Grp Ltd 0.29 $ 52,644,799.96 38 21 -26
IDT IDT Australia Ltd 0.22 $ 47,664,932.80 33 19 63
BD1 Bard1 Life Sciences 0.78 $ 61,060,595.58 4 18 -17
IHL Incannex Healthcare 0.165 $ 178,942,599.33 96 18 146
MX1 Micro-X Limited 0.365 $ 129,363,031.08 46 16 86
PAA Pharmaust Limited 0.12 $ 37,977,590.40 0 14 14
ICS ICSGlobal Limited 2.11 $ 22,205,680.09 23 13 0
PNV Polynovo Limited 3.82 $ 2,512,134,567.20 40 13 115
OIL Optiscan Imaging 0.135 $ 80,558,590.50 36 13 255
DVL Dorsavi Ltd 0.036 $ 10,153,680.10 16 13 45
LBT LBT Innovations 0.14 $ 37,536,576.35 17 12 -15
NEU Neuren Pharmaceut. 1.31 $ 148,990,540.40 27 11 -42
CGS Cogstate Ltd 1.07 $ 182,048,014.17 -18 11 234
1AD Adalta Limited 0.13 $ 34,324,619.42 18 11 25
OSP Osprey Med Inc 0.022 $ 35,713,633.16 10 10 -42
MDC Medlab Clinical Ltd 0.275 $ 72,715,674.46 41 10 -20
NYR Nyrada Inc. 0.25 $ 17,563,897.10 16 9 0
IVX Invion Ltd 0.013 $ 66,444,507.54 18 8 -7
NC6 Nanollose Limited 0.054 $ 6,412,451.13 -13 8 1
ONT 1300 Smiles Limited 7.08 $ 167,642,958.72 10 8 12
PBP Probiotec Limited 2.34 $ 177,225,921.90 34 7 26
RCE Recce Pharmaceutical 1.21 $ 210,190,521.75 27 6 357
LSH Lifespot Health Ltd 0.086 $ 10,727,619.63 30 5 153
PCK Painchek Ltd 0.084 $ 94,651,603.12 -6 5 -58
GLH Global Health Ltd 0.44 $ 17,260,311.20 16 5 203
CYC Cyclopharm Limited 2.6 $ 208,713,583.00 29 4 139
ICR Intelicare Holdings 0.265 $ 9,333,811.50 2 4 0
BNO Bionomics Limited 0.135 $ 88,229,706.00 23 4 49
PSQ Pacific Smiles Grp 2.02 $ 325,452,966.00 2 4 20
CYP Cynata Therapeutics 0.785 $ 91,942,343.14 -13 3 -29
ATH Alterity Therap Ltd 0.032 $ 67,021,349.27 19 3 39
HCT Holista CollTech Ltd 0.066 $ 18,173,039.74 -20 3 -12
AGH Althea Group 0.53 $ 128,360,334.57 31 3 51
S66 Star Combo 0.36 $ 48,496,488.84 4 3 -22
SUD Suda Pharmaceuticals 0.039 $ 11,659,764.28 0 3 -30
BWX BWX Limited 4.02 $ 555,385,112.04 7 3 -10
SOM SomnoMed Limited 2.21 $ 186,208,458.75 17 2 -10
KZA Kazia Therapeutics 1.42 $ 170,955,287.72 73 2 128
SDI SDI Limited 0.81 $ 96,281,079.30 3 1 -6
RAC Race Oncology Ltd 2.09 $ 270,415,226.25 95 1 1167
VLS Vita Life Sciences.. 0.89 $ 48,133,524.68 0 0 37
SVA Simavita Ltd 0.016 $ 18,461,854.56 -11 0 -27
RSH Respiri Limited 0.16 $ 111,497,822.45 -9 0 88
RGS Regeneus Ltd 0.12 $ 31,529,860.01 -4 0 26
PAL Palla Pharma Ltd 0.8 $ 100,128,641.72 13 0 -2
PAB Patrys Limited 0.02 $ 29,661,301.89 -4 0 -8
OVN Oventus Medical Ltd 0.24 $ 40,356,916.34 12 0 -62
MVP Medical Developments 7.05 $ 465,926,786.10 24 0 -3
MDR Medadvisor Limited 0.385 $ 134,295,374.29 -2 0 18
LCT Living Cell Tech. 0.014 $ 8,000,173.73 17 0 -18
IBX Imagion Biosys Ltd 0.13 $ 129,096,404.97 73 0 673
FFC Farmaforce Ltd 0.085 $ 10,945,533.30 21 0 -23
CAJ Capitol Health 0.28 $ 281,902,434.00 6 0 19
BXN Bioxyne Ltd 0.012 $ 7,681,744.78 9 0 -20
BIT Biotron Limited 0.083 $ 54,750,751.61 0 0 41
ATX Amplia Therapeutics 0.225 $ 24,200,804.70 7 0 224
ALT Analytica Limited 0.003 $ 12,318,643.16 50 0 0
AHK Ark Mines Limited 0.034 $ 1,778,919.95 0 0 0
ACW Actinogen Medical 0.021 $ 30,466,530.55 -5 0 -52
ACR Acrux Limited 0.175 $ 28,687,058.51 6 0 -8
1ST 1St Group Ltd 0.041 $ 17,409,293.02 14 0 -44
ZNO Zoono Group Ltd 1.39 $ 224,149,408.59 -9 0 479
NXS Next Science Limited 1.25 $ 154,119,074.54 4 0 -39
CDY Cellmid Limited 0.096 $ 12,023,699.14 -4 -1 -62
RAP Resapp Health Ltd 0.089 $ 68,230,754.01 3 -1 -68
GSS Genetic Signatures 1.77 $ 255,745,795.34 -11 -1 73
VHT Volpara Health Tech 1.36 $ 346,384,251.78 5 -1 -24
AT1 Atomo Diagnostics 0.31 $ 128,485,456.16 -9 -2 0
IMM Immutep Ltd 0.28 $ 175,584,360.66 -3 -2 17
ONE Oneview Healthcare 0.052 $ 11,558,501.93 36 -2 -49
DXB Dimerix Ltd 0.25 $ 49,468,574.25 -6 -2 100
PGC Paragon Care Limited 0.24 $ 82,781,896.54 23 -2 -46
IMC Immuron Limited 0.235 $ 53,306,813.91 3 -2 62
PXS Pharmaxis Ltd 0.089 $ 35,716,981.32 -10 -2 -66
JHC Japara Healthcare Lt 0.685 $ 184,400,656.32 76 -4 -36
EYE Nova EYE Medical Ltd 0.34 $ 48,824,386.92 3 -3 8
MVF Monash IVF Group Ltd 0.72 $ 280,537,084.80 15 -3 -27
AHC Austco Healthcare 0.092 $ 26,145,383.49 -2 -3 37
UBI Universal Biosensors 0.45 $ 84,299,138.25 34 -3 109
OCC Orthocell Limited 0.41 $ 76,686,587.16 21 -4 -19
BOT Botanix Pharma Ltd 0.135 $ 131,314,235.94 48 -4 45
ARX Aroa Biosurgery 1.22 $ 361,590,314.75 -6 -4 0
4DX 4Dmedical Limited 2.25 $ 387,981,084.71 -2 -4 0
TLX Telix Pharmaceutical 3.56 $ 1,034,407,582.50 51 -4 112
PTX Prescient Ltd 0.065 $ 42,276,498.66 8 -4 -35
OSX Osteopore Limited 0.54 $ 42,140,412.00 -4 -4 -34
ALC Alcidion Group Ltd 0.2 $ 208,045,750.92 60 -5 -2
CMP Compumedics Limited 0.495 $ 87,695,659.26 13 -5 -42
IMU Imugene Limited 0.12 $ 552,414,225.48 94 -6 231
GTG Genetic Technologies 0.008 $ 66,093,813.94 7 -6 78
ADO Anteotech Ltd 0.094 $ 166,993,529.45 -4 -6 433
CTE Cryosite Limited 0.31 $ 14,526,464.53 27 -6 474
PYC PYC Therapeutics 0.145 $ 475,638,915.45 -15 -6 161
ADR Adherium Ltd 0.027 $ 18,320,419.62 4 -7 -29
PAR Paradigm Bio. 2.77 $ 641,284,916.32 -8 -7 -22
ANP Antisense Therapeut. 0.097 $ 60,268,757.96 -3 -8 1
MEM Memphasys Ltd 0.12 $ 90,572,865.60 9 -8 135
M7T Mach7 Tech Limited 1.22 $ 300,404,544.00 30 -8 82
BPH BPH Energy Ltd 0.033 $ 18,656,197.77 -25 -8 280
OPT Opthea Limited 2.1 $ 709,094,754.90 -5 -9 -29
VTI Vision Tech, Inc 0.029 $ 28,818,041.21 -3 -9 -51
CDX Cardiex Limited 0.05 $ 41,047,369.87 9 -11 79
IPD Impedimed Limited 0.14 $ 150,723,449.80 68 -11 -11
RNO Rhinomed Ltd 0.15 $ 38,071,369.80 -14 -14 -25
NOX Noxopharm Limited 0.54 $ 118,713,340.61 8 -16 85
MEB Medibio Limited 0.01 $ 13,476,625.69 11 -17 -14
NSB Neuroscientific 0.255 $ 22,591,604.13 -15 -18 21
OSL Oncosil Medical 0.135 $ 113,327,589.78 -18 -18 -19
CBL Control Bionics 0.965 $52,038,777 61
DOC Doctor Care Anywhere 0.835 $136,797,547.09 4

The biggest gainer – by far – has been cannabis company Creso Pharma (ASX:CPH), whose shares were up nearly 16-fold for the month when this list was compiled yesterday afternoon.

After trading for 3c for most of October and November, CPH shares have been on an absolute tear in the last two weeks as talk of the downscheduling of cannibidoil grew louder, reaching as high as 46c around midday Wednesday.

They eased later in the afternoon, closing at 30c – making the stock “just” a ten-bagger in the past fortnight.

Speculation about possible marijuana decriminalisation in the United States and momentum for Creso’s Canadian subsidiary Mernova Medicinal seem to be driving CPH shares.

(Fair warning, though: it’s very unlikely the United States will move on marijuana in the current session of Congress, given that Republicans still control the Senate. The best prospects for federal cannabis reform in the near term is if Democrats win two runoff Senate races January 5 in Georgia).

The second-biggest gainer for the period from November 9 to December 9 was Rhythm Biosciences (ASX:RHY), whose shares were up 238 per cent to 84.5c as the company works to bring its rapid blood test for bowel cancer to market.

Neurotech International (ASX:NTI) was the third-biggest gainer, up 165 per cent to 6.1c as the neurotechnology company made progress on researching its unique strains of hemp.

On the flip side, BPH Energy (ASX:BPH) shares were down 25 per cent to 3.3c – although still up 280 per cent for the year.

At Stockhead, we tell it like it is. Although Creso Pharma and Neurotech International are Stockhead advertisers, they didn’t sponsor this story.